JD vs. CRSP
Compare and contrast key facts about JD.com, Inc. (JD) and CRISPR Therapeutics AG (CRSP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JD or CRSP.
Key characteristics
| JD | CRSP | |
|---|---|---|
| YTD Return | 14.57% | -18.26% |
| 1Y Return | -12.04% | -22.48% |
| 3Y Return (Ann) | -22.12% | -20.96% |
| 5Y Return (Ann) | 4.09% | 4.75% |
| Sharpe Ratio | -0.12 | -0.43 |
| Daily Std Dev | 48.88% | 56.66% |
| Max Drawdown | -79.14% | -81.61% |
| Current Drawdown | -67.80% | -75.64% |
Fundamentals
| JD | CRSP | |
|---|---|---|
| Market Cap | $49.58B | $4.35B |
| EPS | $2.11 | -$1.94 |
| PE Ratio | 15.26 | 403.67 |
| PEG Ratio | 1.20 | -0.21 |
| Revenue (TTM) | $1.08T | $271.71M |
| Gross Profit (TTM) | $84.06B | -$570.70M |
| EBITDA (TTM) | $37.20B | -$279.02M |
Correlation
The correlation between JD and CRSP is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
JD vs. CRSP - Performance Comparison
In the year-to-date period, JD achieves a 14.57% return, which is significantly higher than CRSP's -18.26% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JD vs. CRSP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for JD.com, Inc. (JD) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
JD vs. CRSP - Dividend Comparison
JD's dividend yield for the trailing twelve months is around 2.30%, while CRSP has not paid dividends to shareholders.
| TTM | 2023 | 2022 | |
|---|---|---|---|
JD JD.com, Inc. | 2.30% | 2.08% | 2.21% |
CRSP CRISPR Therapeutics AG | 0.00% | 0.00% | 0.00% |
Drawdowns
JD vs. CRSP - Drawdown Comparison
The maximum JD drawdown since its inception was -79.14%, roughly equal to the maximum CRSP drawdown of -81.61%. Use the drawdown chart below to compare losses from any high point for JD and CRSP. For additional features, visit the drawdowns tool.
Volatility
JD vs. CRSP - Volatility Comparison
JD.com, Inc. (JD) has a higher volatility of 16.07% compared to CRISPR Therapeutics AG (CRSP) at 11.20%. This indicates that JD's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
JD vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between JD.com, Inc. and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities